Hemas Holdings PLC has officially named Sabrina Esufally as an Executive Director on its Board, with the appointment taking effect on July 1, 2026.
Currently, Sabrina Esufally serves as the Managing Director of Hemas Consumer Brands and is a member of the Hemas Group Board of Management.
Joining the Group in 2019, she has held various leadership positions that encompass pharmaceutical manufacturing, business development, innovation, and consumer brands.
Submit Your Press Release
Get your company news, announcements, launches, appointments and events in front of a wider audience.
Under her leadership, Hemas Consumer Brands has emerged as a key part of the Group’s strategic initiatives, successfully entering new consumer segments through innovative practices while enhancing its portfolio of reliable brands.
As Hemas seeks to broaden its reach into frontier markets, Sabrina’s extensive commercial leadership and consumer insights will enrich the Board’s collective knowledge, aiding in the Group’s long-term strategic objectives.
Before her tenure at Hemas, Sabrina was the Head of Legal Research at Verité Research, where she focused on governance and public policy. She is also an Attorney-at-Law with the Supreme Court of Sri Lanka and possesses a First Class Honours degree from the University of Durham, an LL.M. from Harvard Law School, and has attended Harvard Business School.
